Company Updates
Select 3D, an Australian 3D technology company, has designed and developed a dishwasher safe faceshield kit
“Pretty Woman walking down the street” What was Roy Orbinson singing?
Select 3D completes research and development of into a dishwasher safe 3D printing application of engineered medical materials
CropX quadruples YoY sales, reaching 1000+ customers attracting Google’s Eric Schmidt, Finistere Ventures, Bosch and others
“Thanks to the scalability of our solution, despite COVID, 2020 was the best year for CropX since inception. We quadrupled our revenues, signed a strategic deal with irrigation giant Reinke, acquired
Early Education, a sector to watch as post COVID-19 recovery gathers steam
The early education and child care sector has weathered the COVID-19 storm extraordinarily well after a wave of Government funding underwrote its survival and confirmed its status as an “essential
Telix Pharmaceuticals and ITM Complete Global Agreements for Lutetium-177 Radioisotope Supply
Melbourne (Australia) and Garching (Germany) – 18th March 2021. Telix announces it has extended its non-exclusive global clinical and commercial supply agreements with Garching-based ITM AG
With 253,000 passengers to-date and >11,000 trips/month, Shebah is well on track to their IPO
“Shebah does not just move people around, we need to be there for the women travelling at night, families requiring baby seats, vulnerable and elderly passengers, school children of working parents
Elbaite grows trading volumes by 1000% in 6 months on Australia safest cryptocurrency exchange, and files patent for its innovative and world first technology
Highlights
– Elbaite grows trading volumes by 1000% in 6 months
– Patent filed globally for world-first cryptocurrency trading technology
Rapid Response Revival receives confirmation of Clinical Trial Registration and the Appointment of new Non-Executive Director
Registration of Rapid 1 Clinical Trial – First ever Human Trial of a new AED product
RRR can advise the First in Human Clinical Trial, known as the ‘RAPID 1’ trial, has received Ethics Approval and
Venture Capital Fund Manager with portfolio companies trending at a minimum 3x return
“At Moscar, we have carved out a niche in the pre-Series-A space, investing in dynamic cash neutral/positive, bootstrapped companies. Working in close partnership with our portfolio, we prepare them
Novapep now has a complete Peptide Mimetic of Activated Protein C
Prof John Griffin of the Scripps Research Institute and a co-founder of Novapep has a developed a linked form of P1, which Novapep licensed in 2017, and P3. The bivalently linked peptide is called
Backed By Leading Investment Groups and Family Offices
